scispace - formally typeset
Open Access

IgG4-related sclerosing disease

Terumi, +3 more
- Vol. 14, Iss: 25, pp 3948-3955
Reads0
Chats0
TLDR
AIP as discussed by the authors : AIP is a clinicopathological organization that provides a platform for the development and management of medical care.http://www.aip.org.cn/
Citations
More filters
Journal ArticleDOI

Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease.

TL;DR: Treatment with rituximab led to prompt clinical and serologic improvement in these patients with refractory IgG4-RSD, and is a viable treatment option for this condition, suggesting that ritUXimab achieves its effects in IgG 4- RSD by depleting the pool of B lymphocytes that replenish short-lived IgG3-secreting plasma cells.
Journal ArticleDOI

Usefulness of serum IgG4 in the diagnosis and follow-up of autoimmune pancreatitis: a systematic literature review and meta-analysis

TL;DR: The heterogeneity of the studies published until now means that more studies are necessary in order to better evaluate the true accuracy of IgG4 in discriminating AIP versus other autoimmune diseases, and its determination should be included in the diagnostic workup of this disease.
Journal ArticleDOI

IgG4-related sclerosing disease, an emerging entity: a review of a multi-system disease.

TL;DR: The principal histopathologic findings in several extranodal sites include lymphoplasmacytic infiltration, lymphoid follicle formation, sclerosis and obliterative phlebitis, along with atrophy and destruction of tissues.
Related Papers (5)